How many shares of BCRX does BNP PARIBAS FINANCIAL MARKETS own?

As of 2026-Q2, BNP PARIBAS FINANCIAL MARKETS holds 1.2M shares of BCRX (BIOCRYST PHARMACEUTICALS INC).

What is BNP PARIBAS FINANCIAL MARKETS's BCRX position worth?

As of 2026-Q2, BNP PARIBAS FINANCIAL MARKETS's BCRX position is worth $11.7M.

Is BNP PARIBAS FINANCIAL MARKETS buying or selling BCRX?

In 2026-Q2, BNP PARIBAS FINANCIAL MARKETS decreased their BCRX position (-9.8% change in shares).

When did BNP PARIBAS FINANCIAL MARKETS first buy BCRX?

Based on available 13F filings, BNP PARIBAS FINANCIAL MARKETS first reported a position in BCRX in 2018-Q4. They have held the position across 31 quarters.

Back to

BNP PARIBAS FINANCIAL MARKETS

BCRX
31 quarters

Position history for BNP PARIBAS FINANCIAL MARKETS's holdings in BIOCRYST PHARMACEUTICALS INC

Current Value

$11.7M

Current Shares

1.2M

Total Value Change

+$11.7M

Total Shares Change

+1.2M

Quarter-by-Quarter History

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	1.2M	-9.8%	$11.7M	0.0%	$10.00	0
2026-Q1	Decreased	1.3M	-48.8%	$12.4M	0.0%	$8.69	0
2025-Q4	Increased	2.5M	+21.4%	$19.8M	0.0%	$7.66	34
2025-Q3	Increased	2.1M	+43.8%	$15.9M	0.0%	$7.55	38
2025-Q2	Increased	1.5M	+1059.7%	$13.1M	0.0%	$9.36	45
2025-Q1	Decreased	125,627	-36.0%	$942,202	0.0%	$7.86	0
2024-Q4	Decreased	196,225	-60.5%	$1.5M	0.0%	$7.53	0
2024-Q3	Increased	496,784	+472.0%	$3.8M	0.0%	$7.62	43
2024-Q2	Decreased	86,846	-48.2%	$536,708	0.0%	$6.18	0
2024-Q1	Decreased	167,782	-78.8%	$852,333	0.0%	$5.08	0
2023-Q4	Increased	790,163	+45.5%	$4.7M	0.0%	$5.99	37
2023-Q3	Increased	542,968	+151.7%	$3.8M	0.0%	$7.08	43
2023-Q2	Decreased	215,742	-36.6%	$1.5M	0.0%	$6.96	0
2023-Q1	Increased	340,391	+117.4%	$2.8M	0.0%	$8.39	42
2022-Q4	Decreased	156,573	-34.7%	$1.8M	0.0%	$11.48	0
2022-Q3	Increased	239,880	+489.6%	$3M	0.0%	$12.36	43
2022-Q2	Increased	40,682	+57.4%	$430,416	0.0%	$10.81	34
2022-Q1	Decreased	25,845	-60.8%	$420,240	0.0%	$16.44	0
2021-Q4	Increased	65,856	+50.0%	$912,106	0.0%	$13.79	34
2021-Q3	Increased	43,904	+162.1%	$630.9M	0.0%	$14.38	51
2021-Q2	Decreased	16,753	-45.2%	$264,865	0.0%	$15.49	0
2021-Q1	Increased	30,548	+62.8%	$310,673	0.0%	$9.99	34
2020-Q4	Decreased	18,767	-54.5%	$139,814	0.0%	$7.50	0
2020-Q3	Increased	41,204	+15.3%	$141,536	0.0%	$3.84	26
2020-Q2	Decreased	35,737	-49.3%	$170,287	0.0%	$4.98	0
2020-Q1	Increased	70,517	+310.5%	$141,034	0.0%	$1.99	36
2019-Q4	Decreased	17,179	-1.6%	$59,268	0.0%	$3.22	0
2019-Q3	Increased	17,458	+42.4%	$50,017	0.0%	$3.17	28
2019-Q2	Decreased	12,261	-46.0%	$46,469	0.0%	$3.79	0
2019-Q1	Increased	22,711	+613x	$184,868	0.0%	$8.14	37
2018-Q4	New	37	-	$299	0.0%	$7.88	17

Other major holders of BCRX: BlackRock, Inc., BAKER BROS. ADVISORS LP

BCRX31 quarters

BCRX
31 quarters